This post was written by associate professor Michael Pollastri. Neglected tropical diseases are a collection of infectious diseases that primarily affect the poor in developing nations, and many have extremely […]
Thirty two years ago, computer and information science professor Harriet Fell had just given birth to her oldest child when Linda Ferrier, then a PhD student working on her thesis […]
A group of first-year students recently completed the Summer Discovery Experience, an intensive PRISM summer program in which students experience hands-on research in mathematics, physics, and biology.
Pharmacy graduate Nick O’Donnell earned an award at the RISE:2013 expo this spring for his work investigating the adverse effects of intravenous sedatives.
Northeastern’s Professional Science Master’s degree program in biotechnology, now in its 10th year, is a model for similar programs around the world.
A team of engineering students conceived a smart toothbrush at the annual Engineers for the Greater Good competition, winning first place and a $1,500 stipend to turn the concept into reality.
Chemical engineering professor Thomas Webster’s team developed an injectable, conductive material to regenerate heart tissue after either a heart attack or cardiac disease.
Network scientist Alessandro Vespignani, who studies the spread of diseases, explains the pandemic potential of the emerging H7N9 bird flu and why it’s different from past strains.
When the Human Genome Project wrapped in 2003, we assumed this ginormous data set would provide the much needed parts-list to fill in the blanks of human health and disease. […]
Industrial engineering major Kendall Sanderson studies how to use systems engineering to streamline the healthcare industry.
Earlier this month, the Obama administration announced its plan to put $100 million toward building a network map of the human brain. World leading network scientist and Northeastern Distinguished Professor […]
Pharmaceutical sciences professor Barbara Waszczak and graduate student Brendan Harmon devised an intranasal gene therapy that targets the underlying cause of Parkinson’s disease, not just its symptoms.